Background Sickle cell disease (SCD) comprises a heterogeneous group of ... of medical charts was performed to compare maternal and perinatal outcomes in Hb SS, Hb SC disease and sickle-beta ...

Introduction The incidence of feto-maternal complications is high in women with sickle cell disease ... with severe SCD (45 Hb SS plus 2 Hb Sβ0-thalassemia patients) spanning from April 2012 to ...

Were included in the study: -Cases: pregnant women suffering from major sickle cell syndrome (SS, SC, Sβ thalassemia), confirmed by hemoglobin electrophoresis, having given birth at the maternity ward ...

Gallbladder problems are a common complication in individuals with sickle cell disease. These issues often arise due to the breakdown of red blood cells and the subsequent formation of gallstones ...

For those living with sickle cell disease, daily life is a series of obstacles that demand unwavering strength. The condition is relentless, marked by excruciating pain crises, organ damage ...

Greater attendance at the ODU vs. Marshall University men's basketball game could help fund making a little boy's wish.

Brain Age Modeling and Cognitive Outcomes in Young Adults With and Without Sickle Cell Anemia. JAMA Network Open , 2025; 8 (1): e2453669 DOI: 10.1001/jamanetworkopen.2024.53669 Cite This Page : ...

Would the transplant work? What would it look like to have a successful stem cell transplant? Would it be a cure for my sickle cell disease? It was a decision I could think about making because my ...

There will be a blood drive for sickle cell disease this weekend in South Jersey to mark the beginning of Black History Month. Sickle cell disease is the most common inherited blood disorder.

A sickle cell disease “cure” is to be offered to NHS patients for the first time. The £1.65 million gene therapy called exa-cel, also known under the brand name Casgevy, uses a Nobel Prize ...

A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also known as exa-cel, was the first treatment to be licensed using gene ...